Publicly Traded Healthcare Companies in New York

List of Publicly Traded Healthcare Companies Headquartered in New York

The companies on this list are healthcare companies headquartered in New York. Examples of some of the larger companies on this list based on market capitalization include:

Bristol-Myers Squibb Company (BMY)

Henry Schein, Inc. (HSIC)

Pfizer, Inc. (PFE)

Regeneron Pharmaceuticals, Inc. (REGN)

Select the company’s link to access charts, news links and company website and social media information.

Biotech and Pharmaceuticals

Acorda Therapeutics, Inc. (ACOR) (Biopharmaceutical company: neurological disorders)

Actinium Pharmaceuticals, Inc. (ATNM) (Biopharmaceutical company: immunotherapeutics for the treatment of advanced cancers)

Anavex Life Sciences Corp. (AVXL) (Biopharmaceutical company: Alzheimer’s, other CNS diseases; cancer)

Assembly Biosciences, Inc. (ASMB) (Biopharmaceutical company: treatments for hepatitis B virus infection and C. difficile-associated diarrhea)

Athenex, Inc. (ANTX) (IPO June 14, 2017; biopharmaceutical company: cancer)

Avenue Therapeutics, Inc. (ATXI) (IPO June 27, 2017; specialty pharmaceutical company: postoperative pain management)

Axsome Therapeutics, Inc. (AXSM) (IPO in November 2015: Biopharmaceutical company: therapies for pan management and central nervous system disorders)

AzurRx BioPharma, Inc. (AZRX) (IPO October 11, 2016: Development stage biopharmaceutical company focused on gastrointestinal disorders)

BeyondSpring Inc. (BYSI) (IPO March 9, 2017; cancer therapies)

BioSpecifics Technologies Corp (BSTC) (Biopharmaceutical company: injectable collagenase used for treatment of Dupuytren’s contracture and Peyronie’s disease)

Bristol-Myers Squibb Company (BMY) (Biopharmaceutical company: cancer, cardiovascular disease, hepatitis B and hepatitis C, HIV/AIDS, rheumatoid arthritis)

Cleveland BioLabs, Inc. (CBLI) (Biopharmaceutical company: toll-like immune receptor activators; applications in radiation mitigation, oncology immunotherapy and vaccines)

ContraFect Corporation (CFRX) (Therapeutic protein and antibody products for infectious diseases)

Fortress Biotech (FBIO) (Biopharmaceutical company: cancer, additional products in pipeline)

iBio, Inc. (IBIO) (Develops pharmaceutical product applications through its iBioLaunch platform)

Immune Pharmaceuticals Inc. (IMNP) (Antibody therapeutics: inflammatory diseases and cancer)

Intercept Pharmaceuticals, Inc. (ICPT) (Biopharmaceutical company: orphan and more prevalent liver diseases)

bpo-companies

Intra-Cellular Therapies Inc. (ITCI) (Biopharmaceutical company: drugs for the treatment of diseases and disorders of the Central Nervous System)

Kadmon Holdings, Inc. (KDMN) (Biopharmaceutical company developing product candidates within autoimmune and fibrotic diseases, oncology and genetic diseases)    

Keryx Biopharmaceuticals, Inc. (KERX) (Biopharmaceutical company: renal disease)

Ohr Pharmaceuticals, Inc. (OHRP) (Ocular diseases)

Ophthotech Corporation (OPHT)  (Biopharmaceutical company: back of the eye diseases)

Ovid Therapeutics Inc. (OVID) (IPO May 5, 2017; biopharmaceutical company: rare neurological disorders)

Pfizer, Inc. (PFE) (Consumer healthcare products; vaccines; oncology; examples of medicines include treatments for the following areas: cardiovascular/metabolic, inflammation, neuroscience, pain, rare diseases, women’s/men’s health)

Progenics Pharmaceuticals Inc. (PGNX) (Oncology company: diagnostic and therapeutic needs of prostate cancer patients)

Regeneron Pharmaceuticals, Inc. (REGN) (Biopharmaceutical company: Antibody technologies; cardiovascular, diabetes, eye diseases, infectious diseases, inflammation, oncology, pain)

Stemline Therapeutics, Inc. (STML) (Biopharmaceutical company: therapeutics that target cancer stem cells and tumor bulk)

Synergy Pharmaceuticals, Inc. (SGYP) (Biopharmaceutical company: therapies for the treatment of gastrointestinal diseases and disorders)

TG Therapeutics, Inc. (TGTX) (Biopharmaceutical company: B-cell malignancies and autoimmune diseases)

Tonix Pharmaceuticals Holding Corp. (TNXP) (Medicines for common disorders of the central nervous system: fibromyalgia, post-traumatic stress disorder, episodic tension-type headache)

Consumer Healthcare Products

Prestige Brand Holdings, Inc. (PBH) (Brands include Chloraseptic, Clear Eyes, Compound W, Efferdent, Monistat, Luden’s, Nix and PediaCare)

United-Guardian, Inc. (UG) (Healthcare and personal care products)

Diagnostics

Chembio Diagnostics, Inc. (CEMI) (Tests for infectious diseases)

Healthcare Distributors

Henry Schein, Inc. (HSIC) (Health care products and services for animal health, dental, and medical practitioner markets)

Healthcare Research Services

Albany Molecular Research, Inc. (AMRI) (Drug development, discovery and manufacturing)

Healthcare Software and Technology

Medidata Solutions, Inc. (MDSO) (Cloud-based solutions for clinical research in life sciences)

Labs

Enzo Biochem, Inc. (ENZ) (Clinical reference laboratory, biomedical research products, therapeutic treatments for a wide range of diseases)

Medical Devices and Equipment

AngioDynamics, Inc. (ANGO) (Medical devices used treatment of cancer and peripheral vascular diseases)

Bovie Medical Corporation (BVX) (Electrosurgical products and technologies; medical products used in doctor’s offices, surgery centers and hospitals)

Conmed Corporation (CNMD) (Surgical devices and equipment: equipment and devices are used in areas which include gastroenterology, gynecology, neurosurgery, orthopedics and general surgery)

Daxor Corporation (DXR) (Medical devices: blood volume analyzer)

Delcath Systems, Inc. (DCTH)

Fonar Corporation (FONR) (MRI scanners)

MISONIX, Inc. (MSON) (Ultrasonic surgical devices: applications include advanced wound care, neurosurgical, spinal and general surgery procedures)

PAVmed Inc. (PAVM)  (Diversified pipeline of innovative products)

Telehealth

Teladoc Inc. (TDOC) (IPO in July 2015: Telehealth provider)

Leave a Reply

Your email address will not be published. Required fields are marked *